Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Emergent Reversal of Antithrombotics and Treatment of Life-Threatening Bleeding from Coagulopathies: A Clinical Review. J Emerg Med 2022 Jul;63(1):17-48

Date

08/03/2022

Pubmed ID

35918220

DOI

10.1016/j.jemermed.2022.05.011

Scopus ID

2-s2.0-85135179194 (requires institutional sign-in at Scopus site)   2 Citations

Abstract

BACKGROUND: Reversal of antithrombotic agents and treatment of life-threatening bleeding episodes from coagulopathies can be a stressful scenario for clinicians, especially when the selection of treatment options should occur quickly. Understanding the options available for these agents requires emergency physicians to be familiar with the current data surrounding new therapies and dosing strategies for the treatment of bleeding from reversible and nonreversible antithrombotics and coagulopathic conditions.

OBJECTIVE: To provide quick resource guides for the reversal of major or life-threatening bleeding caused by antithrombotic agents or in the setting of coagulopathies.

METHODS: A literature search for articles published through September 2021 related to antithrombotic reversal and treatment of acute bleeding from coagulopathies was conducted using the PubMed clinical database. Selected articles were used to generate 5 guidance tables in this clinical review.

DISCUSSION: Four guidance tables for how to treat major or life-threatening bleeding from antithrombotic agents and 1 table for how to manage life-threatening bleeding for coagulopathies are presented as a quick reference tool for the emergency physician. Additional information on upcoming reversal agents and possible treatment options are provided herein.

CONCLUSIONS: In this clinical review, a series of 5 tables were created to provide quick and comprehensive guidance for the emergency physician when treating major or life-threatening bleeding caused by antithrombotic agents or coagulopathies. © 2022 Elsevier Inc.

Author List

Sperry JD, Rose AE, Williams E, Dierks MR, Medow JE

Author

Joshua E. Medow MD Professor in the Neurology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Anticoagulants
Blood Coagulation Disorders
Fibrinolytic Agents
Hemorrhage
Humans